D.E. Shaw & Co
SVNT

D.E. Shaw & Co’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

D.E. Shaw & Co’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-190,359
Closed -$107K – 4618
2013
Q2 		$107K Buy
+190,359
New +$133K ﹤0.01% 3867

Other funds holding SVNT

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's SVNT Position: Q3 2013 in Review

D.E. Shaw & Co sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2013, closing a stake of 190,359 shares — an estimated $107K sold.

D.E. Shaw & Co first reported a position in SVNT in Q2 2013 and held it in 1 quarter. The position peaked at $107K in Q2 2013. 41 funds tracked by Wall St. Rank hold SVNT as of Q3 2013.

  • D.E. Shaw & Co reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • D.E. Shaw & Co sold 190,359 SAVIENT PHARMACEUTICALS INC shares in Q3 2013, an estimated $107K.
  • D.E. Shaw & Co first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • D.E. Shaw & Co's SAVIENT PHARMACEUTICALS INC position peaked at $107K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2013.

Based on D.E. Shaw & Co's 13F filing for Q3 2013, filed 14 Nov 2013.